Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
0(0%)
Results Posted
6%(1 trials)

Phase Distribution

Ph phase_4
3
19%
Ph phase_1
2
13%
Ph phase_3
5
31%

Phase Distribution

2

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 3Large-scale testing
5(50.0%)
Phase 4Post-market surveillance
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(16)

Detailed Status

Completed16

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 35 (50.0%)
Phase 43 (30.0%)

Trials by Status

completed16100%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT01361399Phase 3

Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold

Completed
NCT01669824

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

Completed
NCT04081831

Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer

Completed
NCT04097912

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

Completed
NCT03904732

Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU

Completed
NCT03603366

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Completed
NCT01117636Phase 3

Evaluate Analgesic Efficacy of Fast Release Aspirin

Completed
NCT02550717

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

Completed
NCT01062360Phase 3

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

Completed
NCT02229461Phase 1

Naproxen Sodium/ASA Platelet Study

Completed
NCT01464983Phase 4

Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache

Completed
NCT01465009Phase 4

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Completed
NCT00963443Phase 3

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold

Completed
NCT01072604Phase 1

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Completed
NCT01464944Phase 4

Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin

Completed
NCT01028079Phase 3

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16